ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Francesco Musumeci
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lappa, A.
Right arrow Articles by Musumeci, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lappa, A.
Right arrow Articles by Musumeci, F.
Related Collections
Right arrow Mechanical Circulatory Assistance
Right arrowRelated Article

Ann Thorac Surg 2007;84:1422-1423
© 2007 The Society of Thoracic Surgeons

Correspondence

HIT in VAD Patients: Considerations

Angela Lappa, MD, Patrizia Picozzi, MD, Emilio D’Avino, MD, Silvia Riondino, MD, Antonio Menichetti, MD, Francesco Musumeci, MD

Department of Cardiovascular Anaesthesia, S. Camillo-Forlanini Hospital, Via Portuense 332, Rome, 00149 Italy

(Email: ppicozzi@scamilloforlanini.rm.it).

The first 20% of the full text of this article appears below.

To the Editor:

We read with great interest the contribution by Koster and colleagues [1]. Unfortunately we found several aspects of the analysis to be rather misleading.

Currently an increased incidence of clinical cases of heparin-induced thrombocytopenia (HIT) has been observed; however the actual incidence has not been documented. There are considerable differences in diagnostic specificity among various laboratory assays to detect HIT antibodies. In their editorial, Warkentin and Crowther [2] criticized Koster and colleagues [1] for their usage of particle gel immunoassay (PaGIA) due to its intermediate specificity (ie, potential over-diagnosis) compared with serotonin-release assay (ie, . . . [Full Text of this Article]


Related Article

Reply
Andreas Koster
Ann. Thorac. Surg. 2007 84: 1423-1424. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. Koster
Reply
Ann. Thorac. Surg., October 1, 2007; 84(4): 1423 - 1424.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.